Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

被引:84
作者
Kim, JM [1 ]
Kim, JS
Kim, N
Jung, HC
Song, IS
机构
[1] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea
[2] Hanyang Univ, Coll Med, Inst Biomed Sci, Seoul 133791, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[4] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul 151, South Korea
关键词
gyrA; mutation; QRDR; resistance;
D O I
10.1093/jac/dki334
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study was to assess the prevalence rate of primary fluoroquinolone resistance in Helicobacter pylori isolates from Korean patients over the past 16 years. Methods: One hundred and thirty-five strains of H. pylori (34 strains in 1987, 36 in 1994 and 65 in 2003) were isolated from antral gastric mucosal biopsy specimens. The determination of MICs for the H. pylori isolates of ciprofloxacin, levofloxacin and moxifloxacin was examined by using the serial 2-fold agar dilution method. DNA sequences of the gyrA gene in fluoroquinolone-resistant strains were determined. Results: The distribution of fluoroquinolone MICs (ciprofloxacin, levofloxacin and moxifloxacin) shifted to higher concentrations during 1987-2003. All of the levofloxacin- or moxifloxacin-resistant strains were resistant to ciprofloxacin. Sequence analysis in fluoroquinolone-resistant strains showed point mutation of the gyrA gene at A272G and G271A, indicating mutations of the codon Asp-91 in the fluoroquinolone-resistance-determining region of the DNA gyrase. Conclusions: These results suggest that resistance to fluoroquinolones has been increasing in the Korean population and the resistance is most likely mediated through point mutation in gyrA.
引用
收藏
页码:965 / 967
页数:3
相关论文
共 10 条
[1]   Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].
Cabrita, J ;
Oleastro, M ;
Matos, R ;
Manhente, A ;
Cabral, J ;
Barros, R ;
Lopes, AI ;
Ramalho, P ;
Neves, BC ;
Guerreiro, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031
[2]   Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection [J].
Cammarota, G ;
Cianci, R ;
Cannizzaro, O ;
Cuoco, L ;
Pirozzi, G ;
Gasbarrini, A ;
Armuzzi, A ;
Zocco, MA ;
Santarelli, L ;
Arancio, F ;
Gasbarrini, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1339-1343
[3]  
Cheon Jae Hee, 2005, Korean J Gastroenterol, V45, P111
[4]   Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands [J].
Debets-Ossenkopp, YJ ;
Herscheid, AJ ;
Pot, RGJ ;
Kuipers, EJ ;
Kusters, JG ;
Vandenbroucke-Grauls, CMJE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :511-515
[5]   In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children [J].
Fujimura, S ;
Kato, S ;
Iinuma, K ;
Watanabe, A .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (10) :1019-1022
[6]   Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy [J].
Heep, M ;
Kist, M ;
Strobel, S ;
Beck, D ;
Lehn, N .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (07) :538-541
[7]   Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea [J].
Kim, JM ;
Mm, JS ;
Jung, HC ;
Kim, N ;
Kim, YJ ;
Song, IS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4843-4847
[8]   NUCLEOTIDE-SEQUENCE OF THE GYRA GENE AND CHARACTERIZATION OF CIPROFLOXACIN-RESISTANT MUTANTS OF HELICOBACTER-PYLORI [J].
MOORE, RA ;
BECKTHOLD, B ;
WONG, S ;
KUREISHI, A ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :107-111
[9]  
NCCLS National Committee for Clinical Laboratory Standards, 2002, 12 INF SUPPL
[10]   Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori [J].
Tankovic, J ;
Lascols, C ;
Sculo, Q ;
Petit, JC ;
Soussy, CJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3942-3944